全球性传播疾病 (STD) 检测市场 – 2029 年行业趋势和预测

性传播疾病 (STD) 检测市场的市场分析和见解

Data Bridge Market Research 分析，到 2029 年，性传播疾病 (STD) 检测市场规模将达到 1587.3455 亿美元，在 2022-2029 年的预测期内，复合年增长率为 7.85%。淋病和衣原体感染病例的增加以及公众对性传播疾病认识的提高是预测期内为性传播疾病检测市场创造新机遇的因素。

性传播疾病是通过性接触传播的疾病。在某些情况下，性传播疾病还可能通过母乳喂养、分娩和共用针头传播。

推动性传播疾病 (STD) 检测市场增长的重要因素包括公众意识的提高和患者教育。此外，全球性传播疾病患病率的上升、通过教育活动提高患者意识以及政府举措的激增预计将推动市场增长。在过去十年中，性传播疾病的患病率和发病率显着上升。随着性传播疾病患病率的上升，世界各国都在致力于实施国家筛查计划，以增加性传播疾病诊断的覆盖率。此外，性传播疾病服务的报销政策也十分有利。这些因素极大地推动了全球性传播疾病检测市场的增长。

预计技术进步和性传播疾病诊断的进步也将推动市场增长。国家筛查计划的实施增加以提高性传播疾病诊断覆盖率也将扩大性传播疾病检测市场。

Lack of patient awareness is likely to hamper the growth of the sexually transmitted diseases (STD) testing market during the forecast period. The side effects of these medications are less severe than those of other treatments. Infection, on the other hand, is a serious constraint. Overdoes of analgesic post-operative pain medication, in particular, are causing a high death rate. These medications are not appropriate for the majority of patients. These factors are limiting the decline and patient interest in these devices.

This sexually transmitted diseases (STD) testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sexually transmitted diseases (STD) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sexually Transmitted Diseases (STD) Testing Market Scope and Market Size

STD testing market is segmented of the basis of disease type and location of testing. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of disease type, the sexually transmitted diseases (STD) testing market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, and other.
• The sexually transmitted diseases (STD) testing market is also segmented on the basis of location of testing. The location of testing segment is further divided into laboratory testing and point of care (POC) testing.

.Sexually Transmitted Diseases (STD) Testing Market Country Level Analysis

The sexually transmitted diseases (STD) testing market is analysed and market size insights and trends are provided by country, disease type and location of testing as referenced above.

The countries covered in the sexually transmitted diseases (STD) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominated the market accounting for the largest share, and this trend is expected to continue throughout the forecast period. This is due to an increase in the number of cases of sexually transmitted diseases in developing countries. Furthermore, increased patient awareness through education campaigns and expanding government initiatives are expected to drive the sexually transmitted diseases testing market growth.

The country section of the sexually transmitted diseases (STD) testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The sexually transmitted diseases (STD) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sexually transmitted diseases (STD) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sexually transmitted diseases (STD) testing market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Sexually Transmitted Diseases (STD) Testing Market Share Analysis

性传播疾病 (STD) 检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对性传播疾病 (STD) 检测市场的关注有关。

性传播疾病 (STD) 检测市场的一些主要参与者包括 bioMérieux SA、BD、Hologic, Inc.、OraSure Technologies, Inc.、Bio-Rad Laboratories, Inc.、Abbott. Merck & Co. Inc.、Johnson & Johnson Services, Inc、GlaxoSmithKline Plc.、Allergen、Bayer AG、Bristol-Myers Squibb Company、Bausch Health Companies Inc.、Boehringer Ingelheim International GmbH、Sorrento Therapeutics, Inc.、WEX Pharmaceuticals Inc.、Zynerba Pharmaceuticals, Inc.、Medtronic、Boston Scientific Corporation、Halyard Health, Inc. 和 Neurotech Na, Inc. 等。

SKU-24256